Kaloba (Pelargonium Sidoides Root Liquid Extraction Preparation (1 : 8-10), Extraction Solvent: Ethanol 11 %)

The extract contains bioactive compounds that exhibit antimicrobial activity and modulate immune function. It is believed to enhance macrophage activity, promote cytokine release, and inhibit bacterial adhesion, thereby supporting the body’s natural defence mechanisms during respiratory infections.

The appropriate dose of Kaloba is determined by the prescribing healthcare professional based on the individual’s age, condition severity and overall health status. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for Pelargonium sidoides during pregnancy and lactation are limited. Women who are pregnant or breastfeeding should consult their healthcare provider before using Kaloba to weigh potential benefits against any unknown risks.

To order Kaloba, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kaloba’s primary active ingredient, Pelargonium sidoides extract, is distinguished by its documented antimicrobial and immunomodulatory properties. Compared with other herbal options such as Echinacea or elderberry, Kaloba has a longer history of use in Europe for acute bronchitis and is formulated as a standardized liquid extract.

Store Kaloba at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is securely tightened after each use.

Kaloba is taken orally as a liquid. The prescribed amount is measured using a calibrated dropper or measuring device provided with the product. It is typically taken with water and may be administered with or without food, according to the prescriber’s guidance.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, widespread rash, or jaundice.

Kaloba should be avoided by individuals with known hypersensitivity to Pelargonium sidoides or any component of the formulation. It is also contraindicated in patients taking warfarin or strong immunosuppressants without medical supervision, and in those for whom a prescriber determines it is unsuitable.